Video: Generative AI and the Future of Health Care, Part 1
Drug Topics
AUGUST 17, 2023
How can Generative AI might improve the health care retail space?
Drug Topics
AUGUST 17, 2023
How can Generative AI might improve the health care retail space?
PharmaVoice
AUGUST 17, 2023
The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 17, 2023
What are some potential applications for Generative AI in the healthcare space?
PharmaVoice
AUGUST 17, 2023
Seattle Congressman Adam Smith's journey with anxiety and chronic health has influenced his perspective on healthcare and pharmaceutical policy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
AUGUST 17, 2023
Kevin is joined by Dr. Thea Blystone, PharmD for a talk about finding fulfillment and satisfaction in the pharmacy world, plus how to find balance between serving others and having time for yourself.
Pharmacy Times
AUGUST 17, 2023
Experts Christina Madison, PharmD, FCCP, AAHIVP, and Joy Hoover, founder of Esōes Cosmetics, sat down to discuss how cosmetics can empower users of all genders.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 17, 2023
The law has impacted the number of physicians receiving payment from drug companies.
Drug Topics
AUGUST 17, 2023
Each year, drug diversion is estimated to cost the US health care system an estimated $70 billion. Outside of these costs, drug diversion poses a significant risk to patient safety and patient’s communities.
Pharmacy Times
AUGUST 17, 2023
A COVID-19 booster dose increased both maternal and cord blood binding and neutralizing antibody levels against virus strains, including Omicron BA.1.
ISPE
AUGUST 17, 2023
2022 Roger F. Sherwood Article of the Year Award Finalists Announced Trudy Patterson Thu, 08/17/2023 - 11:22 iSpeak Blog iSpeak 2022 Roger F. Sherwood Article of the Year Award Finalists Announced ISPE 17 August 2023 Pharmaceutical Engineering ® is delighted to announce the finalists for the 2022 Roger F. Sherwood Article of the Year Award. The articles were selected by judges of 36 feature and technical articles published in Pharmaceutical Engineering during the 2022 calendar year (Volume 42).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 17, 2023
The findings of the study demonstrate the need for preventive interventions for all infants in order to reduce the burden of severe illness from respiratory syncytial virus lower respiratory tract infections.
STAT
AUGUST 17, 2023
When someone says the word embryo, what do you think of? Probably that picture you’ve seen a thousand times on a thousand different news articles: a translucent orb swelling with cytoplasm being prodded by a microinjection needle under the light of a microscope. The mainstreaming of IVF, or in vitro fertilization, has familiarized new generations of people with what the earliest stages of human development entails.
Pharmacy Times
AUGUST 17, 2023
Adjustments for social determinants of health in the US population had a significant impact on cardiovascular disease mortality data between Black and White populations.
STAT
AUGUST 17, 2023
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense. At issue are contracts signed by the South African government with several companies — including Johnson & Johnson and Pfizer — that provided millions of Covid-19 vaccines du
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 17, 2023
The Mylight phase 3 trial confirmed that there was no clinically meaningful differences between aflibercept and its reference biologic, Eylea, for patients with wet macular degeneration.
Fierce Healthcare
AUGUST 17, 2023
David Entwistle has a storied career as a healthcare executive leading new innovations and steering strategic growth at academic medical centers. | Stanford Health Care CEO David Entwistle joined the board of directors at New York City-based Redesign Health. Here are the areas of healthcare he thinks are ripe for innovation.
STAT
AUGUST 17, 2023
A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate the retail networks created by pharmacy benefit managers, dealing a setback to efforts to curtail the dominant role these controversial middlemen play in the pharmaceutical supply chain. The Pharmaceutical Care Management Association, a trade group for pharmacy benefit managers that sued to block the law, objected to Oklahoma’s attempt to “interfere” with efforts to administer health plans tha
Fierce Healthcare
AUGUST 17, 2023
Blue Shield of California today unveiled a new model for pharmacy care that it hopes will overhaul the “broken prescr | Blue Shield of California hopes to cut prescription drugs costs between 10% and 15%, or about $500 million a year, with an ambitious program that sidesteps the pharmacy benefit manager.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 17, 2023
Precision medicine driven by genetic health care is knocking on the door. It offers hope that, sooner than later, we can address health problems like Alzheimer’s disease, cancer, and heart disease that affect the lives of so many Americans. For many patients, the first step will be genetic testing and counseling by a board-certified genetic counselor.
Fierce Healthcare
AUGUST 17, 2023
A recent survey from eHealth, an independent Medicare insurance adviser, released new data that shows 84% of respondents believe Medicare needs reform, but just 12% think changes should impact thei | A new survey shows that while seniors acknowledge Medicare reform is critical to the program's future, they expect to receive benefits at the cost they were promised.
STAT
AUGUST 17, 2023
What difference does a day make? Who gets to have gene therapy? And are biotech startups OK? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays.
Fierce Healthcare
AUGUST 17, 2023
Healthcare Outcomes Performance Company, a national leader in musculoskeletal practice and clinical outcomes management solutions, has partnered with Provider Network Solutions to establish a joint | Under a new joint venture with Provider Network Solutions (PNS) in Florida, HOPCo Network Solutions will add 1,100 new orthopedic, pain management and podiatry partners.
STAT
AUGUST 17, 2023
There are people in your life who influence and shape how you see the world. For me, one of these people is Terry Moakley, a warm and welcoming family friend, a veteran of the Vietnam War, and a fervent advocate for people with disabilities. After he became a quadriplegic as a result of an injury, he began a decades-long career dedicated to improving disability access.
Fierce Healthcare
AUGUST 17, 2023
Mayo Clinic built on its solid first quarter with an even stronger $300 million fro | The nonprofit's six-month revenues are up 9.8% year over year, outpacing an 8.2% rise in expenses. For the second quarter, management attributed its nearly $4.5 billion total revenue to “overperformance in core operations as well as positive investment returns.
pharmaphorum
AUGUST 17, 2023
UK sets aside £210m for antimicrobial resistance project Phil.
Fierce Healthcare
AUGUST 17, 2023
Amid warnings that emergency departments are not fully equipped to meet rising mental and behavioral health (MBH) needs of minors, a trio of healthcare professional organizations is calling for mor | Recent years have cemented emergency departments as critical access points and safety net care providers for kids with mental and behavioral health conditions.
STAT
AUGUST 17, 2023
Blue Shield of California, a health insurance company that covers almost 5 million people, is restructuring how it will pay for prescription drugs by dividing the work up among five different vendors — two of which include Amazon and Mark Cuban’s pharmacy company. Starting in 2024, Blue Shield will rely less on CVS Health’s pharmacy benefit manager, CVS Caremark, a move that led Wall Street to sell off CVS’ stock by more than 9%.
Fierce Healthcare
AUGUST 17, 2023
Pocket Health, a medical image-sharing platform, has launched a tool to help patients stay on top of their follow-up recommendations. | Whether the instructions are to schedule another appointment, tissue sampling or lab work, Follow-Up Navigator will surface them to the patient and prompt them to take action.
European Pharmaceutical Review
AUGUST 17, 2023
The National Institutes of Health (NIH) has chosen contract development, and manufacturing organisation (CDMO) Exothera SA to develop the manufacturing process for its intranasal vaccine against SARS-CoV-2 coronavirus to treat COVID-19. As an alternative drug delivery method to traditional injected vaccines, live, replicating, intranasal vaccines have potential for effectively interrupting transmission of COVID-19 by inducing the development of immunity in the respiratory tract.
STAT
AUGUST 17, 2023
As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry. The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.
Drug Store News
AUGUST 17, 2023
The virtual event, held on Oct. 11-13, seeks suppliers with sustainable products in the food, health and beauty, everyday essentials, pet, apparel and general merchandise categories.
STAT
AUGUST 17, 2023
A feud has erupted between ViiV Healthcare and Doctors Without Borders over a deal to allow the relief organization to purchase an injectable HIV prevention drug, the latest fracas involving the company and efforts to distribute its medication to mostly poor locations around the world. The dispute hinges on a move by the ViiV, which is largely controlled by GSK, to add certain last-minute conditions to a procurement agreement, according to Doctors Without Borders.
pharmaphorum
AUGUST 17, 2023
Changing Faces: Pharma and biotech hires from July 2023 Mike.
Let's personalize your content